Cargando…
RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancer
Muscle-invasive or metastatic bladder cancer (BCa) is associated with a very poor prognosis, and the underlying mechanism remains poorly understood. In this study, we demonstrate RASAL2, a RAS GTPase-activating protein (RAS GAP), acts as a tumor suppressor in BCa. First, RASAL2 was downregulated in...
Autores principales: | Hui, Ke, Gao, Yang, Huang, Jun, Xu, Shan, Wang, Bin, Zeng, Jin, Fan, Jinhai, Wang, Xinyang, Yue, Yangyang, Wu, Shiqi, Hsieh, Jer-Tsong, He, Dalin, Wu, Kaijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386500/ https://www.ncbi.nlm.nih.gov/pubmed/28182001 http://dx.doi.org/10.1038/cddis.2017.9 |
Ejemplares similares
-
The expression and function of RASAL2 in renal cell carcinoma angiogenesis
por: Hui, Ke, et al.
Publicado: (2018) -
RASAL2 regulates the cell cycle and cyclin D1 expression through PI3K/AKT signalling in prostate tumorigenesis
por: Wang, Qi, et al.
Publicado: (2022) -
Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus
por: Zhang, Tingting, et al.
Publicado: (2015) -
The Ras GTPase-Activating Protein Rasal3 Supports Survival of Naive T Cells
por: Muro, Ryunosuke, et al.
Publicado: (2015) -
Suppressive effects of RASAL2 on renal cell carcinoma via SOX2/ERK/p38 MAPK pathway
por: Wang, Sen, et al.
Publicado: (2020)